- Home
- LNKB vs TKNO Comparison
LNKB vs TKNO Comparison
Compare LNKB & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNKB
- TKNO
- Stock Information
- Founded
- LNKB 2018
- TKNO 1996
- Country
- LNKB United States
- TKNO United States
- Employees
- LNKB N/A
- TKNO N/A
- Industry
- LNKB
- TKNO Medicinal Chemicals and Botanical Products
- Sector
- LNKB
- TKNO Health Care
- Exchange
- LNKB Nasdaq
- TKNO Nasdaq
- Market Cap
- LNKB 270.4M
- TKNO 256.9M
- IPO Year
- LNKB N/A
- TKNO 2021
- Fundamental
- Price
- LNKB $7.35
- TKNO $4.64
- Analyst Decision
- LNKB Strong Buy
- TKNO
- Analyst Count
- LNKB 1
- TKNO 0
- Target Price
- LNKB $9.00
- TKNO N/A
- AVG Volume (30 Days)
- LNKB 34.6K
- TKNO 164.3K
- Earning Date
- LNKB 10-27-2025
- TKNO 11-06-2025
- Dividend Yield
- LNKB 4.15%
- TKNO N/A
- EPS Growth
- LNKB N/A
- TKNO N/A
- EPS
- LNKB 1.01
- TKNO N/A
- Revenue
- LNKB $121,982,000.00
- TKNO $38,923,000.00
- Revenue This Year
- LNKB $18.26
- TKNO $9.52
- Revenue Next Year
- LNKB N/A
- TKNO $15.20
- P/E Ratio
- LNKB $7.16
- TKNO N/A
- Revenue Growth
- LNKB 79.01
- TKNO 11.40
- 52 Week Low
- LNKB $6.09
- TKNO $3.94
- 52 Week High
- LNKB $7.98
- TKNO $10.37
- Technical
- Relative Strength Index (RSI)
- LNKB 56.09
- TKNO 55.11
- Support Level
- LNKB $7.03
- TKNO $4.24
- Resistance Level
- LNKB $7.38
- TKNO $4.72
- Average True Range (ATR)
- LNKB 0.20
- TKNO 0.30
- MACD
- LNKB 0.00
- TKNO 0.05
- Stochastic Oscillator
- LNKB 64.00
- TKNO 86.36
About LNKB LINKBANCORP Inc.
Linkbancorp Inc operates in the banking industry. It provides banking services for individuals and businesses such as commercial lending, non-profit banking, treasury management, deposits and loans. Company portfolio segments includes: Agriculture and farmland, Construction, Commercial & industrial, Commercial real estate, Residential real estate, Municipal, customers and Other loans.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.